The protective effects of the melanocortin receptor (MCR) agonist, melanotan-II (MTII), against binge-like ethanol drinking are facilitated by deletion of the MC3 receptor in mice

Neuropeptides

Volumn 48, Issue 1, 2014, Pages 47-51

  Olney, J J ^a   Sprow, G M ^a   Navarro, M ^a   Thiele, T E ^a,b  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Binge like drinking; Ethanol; MC3 receptor; Melanocortin; MTII

Indexed keywords

ALCOHOL; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN RECEPTOR AGONIST; MELANOTAN II;

ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINGE DRINKING; BLOOD SAMPLING; CONTROLLED STUDY; DRINKING BEHAVIOR; GENE DELETION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TAIL; WILD TYPE;

ANIMALIA; MUS;

BINGE-LIKE DRINKING; ETHANOL; MC3 RECEPTOR; MELANOCORTIN; MTII;

ALPHA-MSH; ANIMALS; BINGE DRINKING; ETHANOL; FEMALE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PEPTIDES, CYCLIC; RECEPTOR, MELANOCORTIN, TYPE 3;

EID: 84892676154     PISSN: 01434179     EISSN: 15322785     Source Type: Journal    
DOI: 10.1016/j.npep.2013.11.001     Document Type: Article

References (41)

1. Adan R.A., Gispen W.H. Brain melanocortin receptors: from cloning to function. Peptides 1997, 18:1279-1287.
2. Argiolas A., Melis M.R., Murgia S., Schiöth H.B. ACTH- and alpha-MSH-induced grooming, stretching, yawning and penile erection in male rats: site of action in the brain and role of melanocortin receptors. Brain Res. Bull. 2000, 51:425-431.
3. Bagnol D., Lu X.Y., Kaelin C.B., Day H.E., Ollmann M., Gantz I., Akil H., Barsh G.S., Watson S.J. Anatomy of an endogenous antagonist: relationship between Agouti-related protein and proopiomelanocortin in brain. J. Neurosci. 1999, 19. (RC26).
4. Barrett P., MacDonald A., Helliwell R., Davidson G., Morgan P. Cloning and expression of a new member of the melanocyte-stimulating hormone receptor family. J. Mol. Endocrinol. 1994, 12:203-213.
5. Chen A.S., Marsh D.J., Trumbauer M.E., Frazier E.G., Guan X.M., Yu H., Rosenblum C.I., Vongs A., Feng Y., Cao L., Metzger J.M., Strack A.M., Camacho R.E., Mellin T.N., Nunes C.N., Min W., Fisher J., Gopal-Truter S., MacIntyre D.E., Chen H.Y., Van der Ploeg L.H. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat. Genet. 2000, 26:97-102.
6. Cohen B.H. Explaining Psychological Statistics 2008, John Wiley, Hoboken, N.J.
7. Cowley M.A., Smart J.L., Rubinstein M., Cerdán M.G., Diano S., Horvath T.L., Cone R.D., Low M.J. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 2001, 411:480-484.
8. Daniels E.S., Masheb R.M., Berman R.M., Mickley D., Grilo C.M. Bulimia nervosa and alcohol dependence. A case report of a patient enrolled in a randomized controlled clinical trial. J. Subst. Abuse Treat. 1999, 17:163-166.
9. Dansky B.S., Brewerton T.D., Kilpatrick D.G. Comorbidity of bulimia nervosa and alcohol use disorders: results from the National Women's Study. Int. J. Eat. Disord. 2000, 27:180-190.
10. Dawe S., Staiger P. Case report: treatment of a woman with alcohol and binge eating problems. J. Behav. Ther. Exp. Psychiatry 1998, 29:249-260.
11. Dorr R.T., Lines R., Levine N., Brooks C., Xiang L., Hruby V.J., Hadley M.E. Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study. Life Sci. 1996, 58:1777-1784.
12. Fan W., Boston B.A., Kesterson R.A., Hruby V.J., Cone R.D. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 1997, 385:165-168.
13. Giraudo S.Q., Billington C.J., Levine A.S. Feeding effects of hypothalamic injection of melanocortin 4 receptor ligands. Brain Res. 1998, 809:302-306.
14. Higuchi S., Suzuki K., Yamada K., Parrish K., Kono H. Alcoholics with eating disorders: prevalence and clinical course. A study from Japan. Br. J. Psychiatry 1993, 162:403-406.
15. Holderness C.C., Brooks-Gunn J., Warren M.P. Co-morbidity of eating disorders and substance abuse review of the literature. Int. J. Eat. Disord. 1994, 16:1-34.
16. Jacobowitz D.M., O'Donohue T.L. Alpha-melanocyte stimulating hormone: immunohistochemical identification and mapping in neurons of rat brain. Proc. Natl. Acad. Sci. USA 1978, 75:6300-6304.
17. Koob G.F. A role for brain stress systems in addiction. Neuron 2008, 59:11-34.
18. Koob G.F., Roberts A.J., Schulteis G., Parsons L.H., Heyser C.J., Hyytiä P., Merlo-Pich E., Weiss F. Neurocircuitry targets in ethanol reward and dependence. Alcohol. Clin. Exp. Res. 1998, 22:3-9.
19. Lee M., Kim A., Conwell I.M., Hruby V., Mayorov A., Cai M., Wardlaw S.L. Effects of selective modulation of the central melanocortin-3-receptor on food intake and hypothalamic POMC expression. Peptides 2008, 29:440-447.
20. Lindblom J., Wikberg J.E.S., Bergström L. Alcohol-preferring AA rats show a derangement in their central melanocortin signalling system. Pharmacol. Biochem. Behav. 2002, 72:491-496.
21. Livy D.J., Parnell S.E., West J.R. Blood ethanol concentration profiles: A comparison between rats and mice. Alcohol 2003, 29:165-171.
22. Lowery E.G., Spanos M., Navarro M., Lyons A.M., Hodge C.W., Thiele T.E. CRF-1 antagonist and CRF-2 agonist decrease binge-like ethanol drinking in C57BL/6J mice independent of the HPA axis. Neuropsychopharmacology 2010, 35:1241-1252.
23. Lowery-Gionta E.G., Navarro M., Li C., Pleil K.E., Rinker J.A., Cox B.R., Sprow G.M., Kash T.L., Thiele T.E. Corticotropin releasing factor signaling in the central amygdala is recruited during binge-like ethanol consumption in C57BL/6J mice. J. Neurosci. 2012, 32:3405-3413.
24. Lyons A.M., Lowery E.G., Sparta D.R., Thiele T.E. Effects of food availability and administration of orexigenic and anorectic agents on elevated ethanol drinking associated with drinking in the dark procedures. Alcohol. Clin. Exp. Res. 2008, 32:1962-1968.
25. Marks D.L., Hruby V., Brookhart G., Cone R.D. The regulation of food intake by selective stimulation of the type 3 melanocortin receptor (MC3R). Peptides 2006, 27:259-264.
26. Nash J.F., Maickel R.P. Stress-induced consumption of ethanol by rats. Life Sci. 1985, 37:757-765.
27. National Institute on Alcohol Abuse and Alcoholism (2004). NIAAA council approves definition of binge drinking. NIAAA Newsletter. 3:3.
28. Navarro M., Cubero I., Knapp D.J., Thiele T.E. MTII-induced reduction of voluntary ethanol drinking is blocked by pretreatment with AgRP-(83-132). Neuropeptides 2003, 37:338-344.
29. Navarro M., Cubero I., Chen A.S., Chen H.Y., Knapp D.J., Breese G.R., Marsh D.J., Thiele T.E. Effects of melanocortin receptor activation and blockade on ethanol intake: A possible role for the melanocortin-4 receptor. Alcohol. Clin. Exp. Res. 2005, 29:949-957.
30. Navarro M., Cubero I., Ko L., Thiele T.E. Deletion of agouti-related protein blunts ethanol self-administration and binge-like drinking in mice. Genes Brain Behav. 2009, 8:450-458.
31. Navarro M., Lerma-Cabrera J.M., Carvajal F., Lowery E.G., Cubero I., Thiele T.E. Assessment of voluntary ethanol consumption and the effects of a melanocortin (mc) receptor agonist on ethanol intake in mutant C57BL/6J mice lacking the MC-4 receptor. Alcohol. Clin. Exp. Res. 2011, 35:1058-1066.
32. Ploj K., Roman E., Kask A., Hyytiä P., Schiöth H.B., Wikberg J.E.S., Nylander I. Effects of melanocortin receptor ligands on ethanol intake and opioid peptide levels in alcohol-preferring AA rats. Brain Res. Bull. 2002, 59:97-104.
33. Rhodes J.S., Best K., Belknap J.K., Finn D.A., Crabbe J.C. Evaluation of a simple model of ethanol drinking to intoxication in C57BL/6J mice. Physiol. Behav. 2005, 84:53-63.
34. Rhodes J.S., Ford M.M., Yu C.-H., Brown L.L., Finn D.A., Garland T., Crabbe J.C. Mouse inbred strain differences in ethanol drinking to intoxication. Genes Brain Behav. 2007, 6:1-18.
35. Robbins L.S., Nadeau J.H., Johnson K.R., Kelly M.A., Roselli-Rehfuss L., Baack E., Mountjoy K.G., Cone R.D. Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 1993, 72:827-834.
36. Rockman G.E., Hall A., Glavin G.B. Effects of restraint stress on voluntary ethanol intake and ulcer proliferation in rats. Pharmacol. Biochem. Behav. 1986, 25:1083-1087.
37. Sparta D.R., Sparrow A.M., Lowery E.G., Fee J.R., Knapp D.J., Thiele T.E. Blockade of the corticotropin releasing factor type 1 receptor attenuates elevated ethanol drinking associated with drinking in the dark procedures. Alcohol. Clin. Exp. Res. 2008, 32:259-265.
38. Thiele T.E., Navarro M., Sparta D.R., Fee J.R., Knapp D.J., Cubero I. Alcoholism and obesity: overlapping neuropeptide pathways?. Neuropeptides 2003, 37:321-337.
39. Ugwu S.O., Blanchard J., Nguyen L.D., Hadley M.E., Dorr R.T. A comparison of HPLC and bioassay methods for plasma melanotan-II (MT-II) determination: application to a pharmacokinetic study in rats. Biopharm. Drug Dispos. 1994, 15:383-390.
40. Volkow N.D., Li T.-K. Drug addiction: the neurobiology of behaviour gone awry. Nat. Rev. Neurosci. 2004, 5:963-970.
41. Xia Y., Wikberg J.E., Chhajlani V. Expression of melanocortin 1 receptor in periaqueductal gray matter. Neuroreport 1995, 6:2193-2196.